Genetic variations in multiple myeloma II: association with effect of treatment-Reference-Cited by-同舟云学术

Genetic variations in multiple myeloma II: association with effect of treatment

Published:2011-11-16 Issue:2 Volume:88 Page:93-117
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Vangsted Annette,Klausen Tobias W.,Vogel Ulla

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2011.01696.x/fullpdf

Reference115 articles.

1. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group;Br J Haematol,2003

2. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome;Attal;N Engl J Med,1996

3. Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group;Lenhoff;Blood,2000

4. Impact of age on survival after intensive therapy for multiple myeloma: a population-based study by the Nordic Myeloma Study Group;Lenhoff;Br J Haematol,2006

5. Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of a randomized comparison with vincristine, doxorubicin, and dexamethasone;Mellqvist;Cancer,2008

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Impacts of CYP3A4*1B and CYP3A5*3 Variations on Pharmacokinetic Behavior and Clinical Outcomes in Multiple Myeloma Patients With Autologous Stem Cell Transplant;Cancer Genomics - Proteomics;2022-12-29

2. Single-Cell Proteomics and Tumor RNAseq Identify Novel Pathways Associated With Clofazimine Sensitivity in PI- and IMiD- Resistant Myeloma, and Putative Stem-Like Cells;Frontiers in Oncology;2022-05-11

3. secDrug: a pipeline to discover novel drug combinations to kill drug-resistant multiple myeloma cells using a greedy set cover algorithm and single-cell multi-omics;Blood Cancer Journal;2022-03-09

4. A Single Nucleotide Polymorphism (SNP) in the SLC22A3 Transporter Gene Is Associated With the Severity of Oral Mucositis in Multiple Myeloma Patients Receiving Autologous Stem Cell Transplant Followed by Melphalan Therapy;Anticancer Research;2021-12-29

5. Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients;International Journal of Cancer;2021-03-30